ClinicalTrials.Veeva

Menu

TMS for Complex Regional Pain Syndrome

Stanford University logo

Stanford University

Status

Enrolling

Conditions

Complex Regional Pain Syndromes

Treatments

Device: Transcranial Magnetic Stimulation (TMS)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03137472
25894-3

Details and patient eligibility

About

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-70
  • Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months
  • Average pain level reported on Numerical Rating Scale meets entry criteria
  • Ability to perform the experimental task and procedures.

Exclusion criteria

  • MRI contraindication (metal implants or devices, claustrophobia)
  • TMS Contraindication (eg metal implant or devices near the site of stimulation)
  • History of epilepsy
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Active Treatment
Experimental group
Description:
Participants will receive active TMS in the target area once daily for two days
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)
Sham Treatment
Sham Comparator group
Description:
Participants will receive active TMS in a non-target area once daily for two days
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)

Trial contacts and locations

1

Loading...

Central trial contact

Omar Altirkawi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems